Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 2016

View Archived Issues

New phase I trial explores use of WOKVAC vaccine to prevent breast cancer recurrence

NIH award supports pancreatic cancer study of CivaSheet

Zydus Cadila and Takeda Pharmaceutical partner to tackle chikungunya

NCI awards contract to BioMarker Strategies for predictive test in NSCLC

ResistancePlus MG assay awarded CE-IVD mark

U.S. phase I study of oral OTS-167 to begin in breast cancer

Adgero Biopharmaceuticals obtains financing to support development of REM-001

MabVax Therapeutics gives update on phase I study of MVT-5873

Prozymex patents DPPI inhibitors

Teva and Regeneron enter global collaboration to develop and commercialize fasinumab

Asthma exacerbation model mimics the effects of viral respiratory infections

Amgen's phase III GLAGOV study of evolocumab meets endpoints

Sunovion Pharmaceuticals reports results from pivotal trial of dasotraline in ADHD

BioLineRx begins phase IIa study of BL-8040 plus pembrolizumab in pancreatic cancer

Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors

EMA validates BMS' application to extend Opdivo indications

Long-acting growth hormone CJ-40002 is safe and effective in phase I trial

Amgen describes Nav1.7 channel blockers

Mirna Therapeutics stops phase I trial of MRX-34 following immune-related severe adverse events

BioNTech and Genentech to develop individualized mRNA-based cancer vaccines

Allergan to acquire Tobira Therapeutics

FDA grants fast track designation to Viaskin Milk

Phase III study of vepoloxamer in sickle cell disease does not meet primary efficacy endpoint

Bionomics reports promising phase II results for BNC-210 in generalized anxiety disorder

Kite Pharma signs license with NIH to target KRAS driven cancers

Serum NFL shows promise as a biomarker in RRMS

FDA grants orphan drug designation to CC-122

Follistatin gene therapy receives FDA orphan designation for inclusion body myositis

New biomarkers could help differentiate CIS patients from other forms of multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...